Randomised controlled trial of carbamazepine assisted detoxification in patients with benzodiazepine dependence
ISRCTN | ISRCTN44535130 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN44535130 |
Secondary identifying numbers | N0133160479 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 27/10/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Chris Daly
Scientific
Scientific
Wentworth House
Mental Health Services of Salford
8 Westminster Road
Eccles
Salford
M30 9HF
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Randomised controlled trial of carbamazepine assisted detoxification in patients with benzodiazepine dependence |
Study objectives | 1. Carbamazepine minimizes severity and incidence of benzodiazepine withdrawal symptoms. 2. Carbamazepine assisted detoxification increases the abstinence rates of benzodiazopines in short term. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Mental and Behavioural Disorders: Addiction |
Intervention | 1. Carbamazepine assisted benzodiazepine detox for 2 weeks 2. Traditional gradual withdrawal of diazepam Observers will be blinded from allocation of groups. Analysis of Variance (ANOVA) will be used to compare 2 groups. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Carbamazepine |
Primary outcome measure | 1. Benzodiazepine withdrawal symptom questionnaire (30 items) 2. Hamilton Depression Rating Scale (17 items) HAM-D) 3. Hamilton Anxiety Rating Scale (HAM-A) 4. Abstinence rates from benzodiazepines Patients will be assessed at 3 points: 1. Baseline 2. 1 week after starting the detoxification 3. 2 weeks (end of detoxification) Follow-up interview or phone call will be made 4 weeks after discharge asking if patient are abstinent from benzodiazepines. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 21/09/2004 |
Completion date | 30/05/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 65 Years |
Sex | Both |
Target number of participants | Target total for recruitment: 50 |
Key inclusion criteria | Patients (18-65 years) who are admitted to Wentworth House or Kenyon House in-patient units, and are using daily doses of benzodiazepine for at least 3 months. |
Key exclusion criteria | 1. Significant psychiatric disorders (by ICD 10) 2. History of or current liver failure 3. Current Alanine Transaminase ( ALT) > or equal 150 IU/l in serum LFT 4. Current suicidal ideation 5. Patients who are already on Carbamazepine before referral for In Patient treatment. |
Date of first enrolment | 21/09/2004 |
Date of final enrolment | 30/05/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Wentworth House
Salford
M30 9HF
United Kingdom
M30 9HF
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Bolton, Salford and Trafford Mental Health NHS Trust (UK), NHS R&D Support Funding
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |